Blood purification equipment market seen growing to $33.23B by 2030

The blood purification equipment market is projected to rise from $21.81 billion in 2025 to $33.23 billion by 2030, driven by more kidney transplants, critical care demand and broader use of dialysis-based therapies. Asia-Pacific led the market in 2025, while portable devices and continuous blood purification systems are shaping the next phase of growth.

Why it matters: - The blood purification equipment market is tied to critical care, kidney disease treatment and post-transplant recovery. - Demand is rising as hospitals, transplant centers and home-care providers look for faster and more flexible ways to remove toxins and manage fluid balance. - The market’s projected 8.8% CAGR signals sustained spending on filtration and dialysis technologies through 2030.

What happened: - The Business Research Company said the blood purification equipment market is projected to grow from $21.81 billion in 2025 to $23.73 billion in 2026. - The same report forecasts the market will reach $33.23 billion by 2030. - The report was published July 29, 2026. - Asia-Pacific was the largest regional market in 2025. - The report also covers South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - Blood purification equipment includes hollow-fiber membrane devices used in critical care nephrology. - The devices clean blood through diffusion, convection and ultrafiltration. - The equipment filters toxins and removes damaged red blood cells. - Historical growth has been supported by rising cases of renal failure and sepsis. - Expanded intensive care infrastructure has also helped demand. - Wider adoption of dialysis-based therapies has added to market growth. - Improvements in hollow-fiber membrane design have strengthened the technology base. - More hospital admissions for critical illnesses have increased equipment use. - The report points to stronger demand for home-based blood purification solutions. - Early toxin removal treatments are gaining more focus. - Portable devices are becoming more common. - Investment is increasing in advanced filtration technologies. - Adoption is rising in emerging healthcare markets. - The report highlights growing use of continuous blood purification systems. - Compact and portable devices are seeing broader uptake. - Sophisticated membrane technology is being integrated into new products. - Critical care settings are using blood purification equipment in more applications. - Patient-specific treatment protocols are becoming more important. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - Kidney transplantation is a key demand driver because post-transplant patients often need help managing medications, electrolytes and fluid levels. - The transplant trend adds a procedural tailwind for equipment makers serving nephrology and critical care. - The report’s emphasis on portability suggests the market is moving beyond only hospital-based treatment. - The focus on emerging markets and home care points to broader access and more decentralized treatment models.

What's next: - The market is expected to keep growing at an 8.8% CAGR through 2030. - Growth will likely track demand for home-based systems, portable devices and advanced filtration platforms. - Continued adoption in emerging healthcare markets could expand the market’s geographic footprint. - Ongoing upgrades in membrane technology may shape competitive positioning over the forecast period.

The bottom line: - Blood purification equipment is moving from a specialized critical care category toward a wider, more portable and more globally adopted treatment market.